Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
well the fact that an insider exercised options is a good thing too.
we wait to see. hopefully at the conference some institutions see the potential and jump on board.
looking like we might get thru today. i added 1400 shares today. lets goo. i am tapped out now.
we need to push thru this damn 1.45 resistance. hopefully end of day or monday doest it for us. after that real light to 1.70
i doubt its rallying because of the too nice thing. its moving along its course. it probably helped a lil too. Asco presentation as i stated in the past it will rise just on speculation. we shd test 1.70 soon.
and then there is action on this board again. lets see what happens next week. should be very ineteresting. any thoughts on the clinical trials.
bought march 5 my lotto play. if and when fund managers jump on this we flyyyyy.
i doubt the fed will sell into open market. i bet they will probably sell to it in batches/lots to mutual funds/hedge funds/ private companies.
next week shd be interesting when the lock is off.
http://www.streetinsider.com/Analyst+Comments/Bove+Says+Citigroup+%28C%29+Could+Double+to+%248.50Share/5430153.html
Bove Says Citigroup (C) Could Double to $8.50/Share
even analyst pump. lets gooooo
y $ 10. bla filing, bk emergence & approval of dndn. cud be more than we bargained for. check nwbo its a sleeper right now.
y $ 10. bla filing, bk emergence & approval of dndn. cud be more than we bargained for. check nwbo its a sleeper right now.
speculation alone should drive it back up to 52 week high hopefully. there is a shareholder meeting on the 26th of this month correct??
we wait for march then.
come may this can be as much as $ 5 buck load up. it will fly when dndn is aproved for provenge. DNDN will be the first cancer vaccine approved by the FDA. So its only right that related companies ride the momentum as well. got my lil shares ready.
good luck.
http://seekingalpha.com/instablog/401845-michael-catalin-vlaicu/8815-nephros-otc-neph-three-fda-decisions-one-company
according to this persons calculation should be around $ 7 or more. but of course the market decides
$ 8
i guess with these type of companies you just wake up one day and be very excited. we wait to see. i also like the low key of the company not a lot of eyes on this. i bought some addtional share when it had the big drop.
well i bought in low around .52 to .62 i already doubled up and sold my half. i am very conservative. i dont need to get rich of one stock. just need to make money
you aint lying. it will really fly on any news.i got my eye on march 2010. shd rise due to report thats due around that time.
how did you find this company anyway.
ShakabudakaMan i have added you as an assitant. please follow the guidelines. thank you
as far as this company. this is the waiting period. i assume the next or any announcements would most likely be some partnership news or maybe additional funding from private placement. The major news on the study will also be annouced in March which is only 3 months away. so now we just wait. i work 9 to 5 so i havent really been able to find any new information. but i think there is not that much information to be found anyway. we wait and keep adding. you dont want to be the one saying i should have bought more. we all say that.
check this out. outlook of medical devices for 2010
http://www.emergogroup.com/files/uploads/research/emergo-medical-device-industry-outlook-2010.pdf
you aint lying i just started following this in october. damn how do yall end up with that much money to buy that many shares? whats the secret? i hold about 2000 shares :).
this is a wild theory. but hear me out. quest diagnostics recently raised 750 million. according to sources or word online they plan to buy out a diagnostics commpany for cash. of course the obvious company to buy out would be vermnillion. since they partnered with them in making that ovarian cancer test. It dosent really say the name of the company.
but it does say a "diagnostics testing company." This company is also a diagnostic testing company"
of course this is just in my head.
i think today we break the $1 mark. hey southgirl do you have level 2 ????
i doubt dilution. if they do i will buy some more shares anyway. this is kinda of similar to vrmlq (which is going thru the roof.)
they have money to last them thru the first quater of 2010 and alot of the debt they are not paying interest on it till it matures. in all i hope the fda comes thru. i belive in the technology shd be a banger when its all said and done. from the way its trading you can tell people are holding onto their shares.
New 10q report filed today.
http://biz.yahoo.com/e/091112/gthp.pk10-q.html
nothing major in there that we dont already know. they do mention that they are going thru the fda review process. next week should be very interesting. lloking to see if they get some big name partners.
damnnnn. how long have you been following this company. this only came to my attention because i owned neph. and there was a report written about NEPH that had some correlation to GTHP. that's when i started to get interested.
as we speak its undergoing the fda review process. they are anticipating a 2010 INTERNATIONAL launch. that's right around the corner. Medica should be great. in terms of partnerships and sheeding some new light on this technology. if you read through the old sec filings you will notice revenue estimates of 1.25 billion now thats some big numbers for this small company. patience will reward us well.
how many shares are you holding by the way.
http://finance.yahoo.com/news/Guided-Therapeutics-to-bw-1239170392.html?x=0&.v=1
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP - News) today announced plans to introduce its LightTouch™ non-invasive cancer detection technology at Medica 2009 in Düsseldorf, Germany November 18 - 20, 2009.
GT will be showcasing the LightTouch Cervical Neoplasia Detection System in anticipation of a 2010 international launch. GT intends to meet with medical device distributors with gynecological market expertise, as well as government purchasing officials, in order to better understand the cervical cancer market structure in the various countries.
The company is also looking to identify physicians who specialize in colposcopy and cervical disease management in the interest of establishing partnerships for multinational clinical studies involving the LightTouch.
“We believe the LightTouch will significantly improve the standard of care in the area of cervical pre-cancer detection in a wide range of market settings,” said Mark L. Faupel, Ph.D., President and CEO of GT. “Our experience in launching new non-invasive detection technology indicates an international product launch
- while the technology is undergoing U.S. FDA premarket review - permits us to have an earlier, positive affect on woman’s healthcare while increasing shareholder value.”
In conjunction with its partner Konica Minolta Opto, Inc. of Tokyo, GT will also be holding design and feature requirement discussions with international healthcare professionals for its LightTouch technology for detecting and monitoring Barrett’s esophagus.
In cooperation with the Georgia Department of Economic Development, Guided Therapeutics will be exhibiting in the North American Pavilion at Hall 16 D10-8. Medica is the world’s largest medical industry tradeshow and more than 135,000 visitors from over 100 countries are expected to attend this annual event
they have already filed for fda approval. if you read the latest pr. they say they are going through the fda premarket process.
i think the rally is just warming up. watch out vrmlq we are about to pass that. with approval this will easily hit 3 bucks. and when orders start flowing in. who knows where the price will be. glta
hope this is the start of the upward strength. glta.
lets get this billion dollar market share. market potential of this device is 1.25 billion annually. this estimate is just USA & Europe. Mckay group already ordered a 1000 units.
i guess i am the only one following this company. we some great news came out today. i dont like how the news was worded. it looks misleading untill u actually read it and see what they mean.
any way i am long on this. lets see what happens with the upcoming medica 2009 and aslo the sharholders meeing coming up.
medica 2009. lets go. 2010 international launch should be interesting. i hope they get to partner with some big boys at the medica event. then we should really take off
i just started following this company. from what i can find they are planning to launhc this device internationally and alos file with the fda. anyone has any insight on this.
thank you
this might help out for all the 510k applicants.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm183497.htm
reason i am holding. goldman sachs bought a while back. with these guys posting record breaking profits i will just follow the money. check out the other institutions holding too.
http://www.mffais.com/mesa
it just moved up heavy. don't know but i like it. i hope they have some partnership to announce during this CC
bid .0653 ask .0655